Upgrades

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst John DiFucci upgraded Zscaler Inc (NASDAQ:ZS) from Neutral to Buy. Zscaler...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by...

Top Wall Street analysts updated their views on several notable stocks. For a complete view of all analyst rating changes, including upgrades and downgrades, please see the analyst ratings page. Ascendiant Capital lowered the price target for GRI Bio, Inc. (NASDAQ:GRI) from $40.00 to $32.00....

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BofA Securities analyst Tal Liani upgraded SentinelOne Inc (NYSE:S) from Neutral to Buy and...

Shares of Agilent Technologies Inc (NYSE:A) traded higher on Thursday, after the company reported upbeat fiscal first-quarter results. Here are the key analyst insights: BofA Securities analyst Michael Ryskin upgraded the rating from Neutral to Buy, while cutting the price target from $150 to $145...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Derik De Bruin upgraded Agilent Technologies, Inc. (NYSE:A) from...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Mike Matson upgraded ICU Medical Inc (NASDAQ:ICUI) from Hold to Buy and...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. TD Cowen analyst Itay Michaeli upgraded Lear Corporation (NYSE:LEA) from Hold to Buy and...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Craig Bijou upgraded Haemonetics Corp (NYSE:HAE) from Neutral to Buy...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Argus Research analyst Taylor Conrad upgraded Etsy, Inc. (NYSE:ETSY) from Hold to Buy and...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst John Freeman upgraded SM Energy (NYSE:SM) from Underperform to Outperform...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst Curry Baker upgraded Stubhub Holdings, Inc (NYSE:STUB) from Neutral to Buy...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James analyst Buck Horne upgraded Invitation Homes Inc (NYSE:INVH) from Market Perform...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst J. Bruce Chan upgraded RXO Inc (NYSE:RXO) from Hold to Buy and announced a $22...

USA Rare Earth (NASDAQ:USAR) is shaping up as the go-to rare earth stock in the West, according to Cantor Fitzgerald. The firm's analysts, Derek Soderberg and Drew Nordquist, raised their 12-month price targets to $35 from $30, reiterating an Overweight rating. There are several catalysts...